POMDOCTOR Ltd filed a Form F-1 registration statement for an initial public offering on 2025-03-13. It has amended it 7 times. It filed its final prospectus on 2025-10-09. Each fact below is quoted from the filing named with it.
What the filings say
Listing
Our ADSs have been approved for listing on the Nasdaq Global Market (the “Nasdaq”) under the symbol “POM.”From the 424B4 filed 2025-10-09
Shares offered
This is an initial public offering of 5,000,004 American depositary shares, or ADSs, by POMDOCTOR LIMITED, a holding company incorporated in the Cayman Islands with its operations conducted by its subsidiaries and contractual arrangements with its variable interest entity (the “VIE”).From the 424B4 filed 2025-10-09
Use of proceeds
We intend to use the net proceeds from this offering for our supply chain stocking, the expansion of our departmental and geographic coverage, research and development, as well as working capital and general corporate purposes.From the 424B4 filed 2025-10-09
Net loss or income
For the years ended December 31, 2023 and 2024, we have incurred net losses of RMB36.9 million and RMB37.4 million (US$5.1 million), respectively.From the F-1/A filed 2025-09-19
Timeline
| Filed | What it is | Filing |
|---|---|---|
| 2025-03-13 | Registration statement filed (foreign issuer) | F-1 |
| 2025-03-31 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-06-17 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-07-15 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-08-05 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-08-28 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-09-19 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-09-26 | Registration statement amended (foreign issuer) | F-1/A |
| 2025-10-09 | Final prospectus filed: the offering is priced | 424B4 |
Tools for this story
Each opens in a new tab, filled in for POMDOCTOR Ltd. With no account yet, you sign up free and land on the result.
Where this comes from
A company that wants to sell shares to the public in the United States files a registration statement with the SEC: Form S-1 for a US company, Form F-1 for a foreign one. It amends that statement as the figures and terms are filled in, usually adding the expected price range shortly before the offering. Once the offering is priced it files its final prospectus under Rule 424(b)(4). A company that decides not to go ahead can ask for the registration statement to be withdrawn on Form RW.
Every row on this page is one of those filings, linked to the filing itself. The facts are the company's own sentences, quoted from the filing named beside each one and never reworded; where no filing states a fact in a sentence that can be read exactly, this page leaves it out. A filing is the company's statement of its plans and its figures, not a verification of them, and nothing here is investment advice.